Medicxi, a life sciences venture capital firm, specializes in drug discovery and therapeutics development.
Location
London, Greater London, GB
Founded
2016
Medicxi is a venture capital firm specializing in the life sciences sector, with a particular focus on drug discovery and the development of therapeutics for unmet medical needs. Established in 2016 by the former Index Ventures life sciences team, Medicxi leverages over 20 years of experience in the industry. The firm typically invests in various stages, including Series A, B, and D rounds, with investment amounts ranging from $10 million to over $75 million.
Notable portfolio companies include Aldena Therapeutics, Diasome Pharmaceuticals, Fore Biotherapeutics, and Rivus Pharmaceuticals. Key partners at Medicxi bring a wealth of expertise from their tenure at Index Ventures. The firm is known for its deep industry knowledge and hands-on approach, offering strategic guidance and operational support to its portfolio companies. This unique value-add service helps startups navigate the complexities of drug development and commercialization.
Medicxi - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
